Home LiteratureArticle Details
PMID: 1370773 Published · ppublish English Journal Article

Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.

Clinical and experimental immunology ·Vol. 87 ·No. 1 ·1992-01-00 ·Pages 37-45

Bell SJ, Cooper DA, Kemp BE, Doherty RR, Penny R

Abstract

The majority of the immunodominant amino acid sequences of HIV-1 that have been characterized to date are coded for by hypervariable gene sequences. These variable sequences are however interspersed with sequences that are highly conserved between HIV strains. Immunogenic viral products with amino acid sequences that vary minimally between strains, and that consistently elicit both humoral and cellular immune responses, may be ideal for inclusion in a subunit vaccine. We studied HIV-seronegative and HIV-infected persons, classified as asymptomatic (AS), ARC or AIDS. Initially, we assessed the cellular immune status of each subject from results of T cell phenotype analyses, assays for serum levels of surrogate markers of disease progression, and responses to mitogens and recall antigen. In addition, we tested whether three short synthetic peptides derived from the conserved sequences of the envelope gp120 (aa 262-284) and gp41 (aa 579-601), and core p17 (aa 106-125) regions of the HTLV-IIIB isolate, could elicit B cell as well as T cell responses in HIV-infected subjects. Only the gp41-derived sequence was immunogenic at both B and T cell levels. To further characterize the gp41 epitope, we used a series of overlapping synthetic peptides derived from a conserved region of the envelope gp41 (aa 572-613). We thus identified an immunodominant 12-mer peptide sequence, gp41(8)(aa 593-604), which consistently elicited both T cell blastogenic and B cell (antibody) responses in AS HIV-seropositive individuals but not in ARC and AIDS patients. Linear regression analysis showed that in AS persons there was a strong positive correlation (P less than 0.0005) between the absolute CD8+ T cell numbers and the magnitude of blastogenic responses to the gp41(8)(aa 593-604). Furthermore, those AS subjects with T cells that proliferated in response to this gp41 analogue also had significantly greater serum levels of antibody to the same short peptide sequence than symptomatic ARC and AIDS patients. These results suggest that cellular responses to the immunodominant and highly conserved envelope sequences of HIV-1, associated with increased CD8+ T cells, may be important in the pathogenesis of HIV disease.

MeSH Terms
Amino Acid Sequence B-Lymphocytes/immunology Epitopes/analysis HIV Core Protein p24/analysis HIV Envelope Protein gp41/immunology HIV-1/immunology Humans Lymphocyte Activation Molecular Sequence Data Peptide Fragments/immunology Phenotype T-Lymphocytes/immunology
Chemicals
Epitopes HIV Core Protein p24 HIV Envelope Protein gp41 Peptide Fragments
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bell S J
Centre for Immunology, St. Vincent's Hospital, Sydney, Australia.
Cooper D A
Kemp B E
Doherty R R
Penny R
References (33)
33 references, click to expand
  1. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
    J Immunol. 1987 Dec 15;139(12):4027-33 PMID: 2447158
  2. Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5038-42 PMID: 3014529
  3. Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.
    Immunology. 1989 Aug;67(4):453-9 PMID: 2475432
  4. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1.
    J Virol. 1989 Aug;63(8):3257-60 PMID: 2526228
  5. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.
    Cell. 1989 Sep 8;58(5):901-10 PMID: 2550139
  6. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.
    J Acquir Immune Defic Syndr. 1989;2(4):344-52 PMID: 2754611
  7. Genomic diversity of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Aug 23;229(4715):759-62 PMID: 2992084
  8. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
    Ann Intern Med. 1988 Feb;108(2):175-80 PMID: 3124680
  9. B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus.
    J Virol. 1988 Aug;62(8):2531-6 PMID: 3260630
  10. Autologous red cell agglutination assay for HIV-1 antibodies: simplified test with whole blood.
    Science. 1988 Sep 9;241(4871):1352-4 PMID: 3413497
  11. Monitoring of solid phase peptide synthesis by an automated spectrophotometric picrate method.
    Anal Biochem. 1975 May 12;65(1-2):241-72 PMID: 1130679
  12. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.
    J Virol. 1990 Nov;64(11):5301-5 PMID: 1698995
  13. Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production.
    Clin Exp Immunol. 1990 Apr;80(1):44-8 PMID: 1969780
  14. Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques.
    J Virol. 1990 Jan;64(1):113-9 PMID: 2152808
  15. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
    Cell. 1986 Jun 6;45(5):637-48 PMID: 2423250
  16. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.
    J Virol. 1987 Jun;61(6):2024-8 PMID: 2437327
  17. Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.
    J Virol. 1987 Aug;61(8):2639-41 PMID: 2439707
  18. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.
    J Immunol. 1989 Jan 15;142(2):452-62 PMID: 2463308
  19. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    N Engl J Med. 1989 Oct 26;321(17):1141-8 PMID: 2477702
  20. Markers for progression in HIV infection.
    AIDS. 1989;3 Suppl 1:S153-60 PMID: 2575397
  21. Extensive variation of human immunodeficiency virus type-1 in vivo.
    Nature. 1988 Aug 4;334(6181):440-4 PMID: 3405290
  22. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Nature. 1987 Jul 23-29;328(6128):345-8 PMID: 3496541
  23. Serial CD4 lymphocyte counts and development of AIDS.
    Lancet. 1991 Feb 16;337(8738):389-92 PMID: 1671424
  24. Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies.
    AIDS. 1990 Jan;4(1):83-6 PMID: 1690552
  25. Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):9938-42 PMID: 1702224
  26. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    N Engl J Med. 1990 Jan 18;322(3):166-72 PMID: 1967191
  27. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers.
    J Med Virol. 1990 Oct;32(2):128-33 PMID: 2126281
  28. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
    Proc Natl Acad Sci U S A. 1990 Apr;87(8):3185-9 PMID: 2326277
  29. Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides.
    J Exp Med. 1990 Sep 1;172(3):889-99 PMID: 2388036
  30. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
    J Virol. 1987 Feb;61(2):570-8 PMID: 2433466
  31. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5225-9 PMID: 2455899
  32. Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.
    Lancet. 1988 Apr 23;1(8591):902-5 PMID: 2895830
  33. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus.
    J Infect Dis. 1987 Aug;156(2):261-7 PMID: 2439614
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1992-01-00
Pages
37-45
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1554222
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com